Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
t3d-959 (2 trials)
Alzheimer Disease (Phase 2)
Trials (2 total)
Trial APIs (1 total)